Rol del tratamiento sistémico en el cáncer gástrico

Natalia  Ferrari

doi:10.33734/diagnostico.v60i2.286

Authors

Natalia Ferrari 1Médico-Cirujana, Hematóloga, Oncóloga https://orcid.org/0000-0002-5641-7273

DOI:

https://doi.org/10.33734/diagnostico.v60i2.286

Keywords:

Gastric cancer, adjuvant treatment, neoadjuvant treatment, treatment of metastatic disease, systemic treatment

Abstract

Gastric cancer can be cured surgically when found in early stages, but it is still a deadly disease
in many cases, especially when found in more advanced stages. Systemic and regional treatments have been added to surgery to improve the outcomes in localized disease. Systemic treatments are also used in advanced
or metastatic disease to improve survival y palliate symptoms. Cytotoxic therapy, immunotherapy, monoclonal antibodies, other targeted therapies, and combinations of these have improved the survival in the metastatic setting.